Global Anticancer Drug Market Growth (Status and Outlook) 2025-2031

October 2025 | 95 pages | ID: GEC695E9B881EN
LP Information

Abstracts

According to this study, the global Anticancer Drug market size will reach US$ 172570 million by 2031.

Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Anticancer Drug Industry Forecast” looks at past sales and reviews total world Anticancer Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Anticancer Drug sales for 2025 through 2031. With Anticancer Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anticancer Drug industry.

This Insight Report provides a comprehensive analysis of the global Anticancer Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anticancer Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anticancer Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anticancer Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anticancer Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Anticancer Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Targeted Drugs
• Cytotoxic Drugs
• Hormonal Drugs
• Others

Segmentation by Application:

• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Hormonal Therapy
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Celgene
• Pfizer
• Bristol-Myers Squibb
• Novartis
• AstraZeneca
• Teva Pharmaceuticals
• Bayer
• GlaxoSmithKline

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anticancer Drug Market Size (2020-2031)
  2.1.2 Anticancer Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Anticancer Drug by Country/Region (2020, 2024 & 2031)
2.2 Anticancer Drug Segment by Type
  2.2.1 Targeted Drugs
  2.2.2 Cytotoxic Drugs
  2.2.3 Hormonal Drugs
  2.2.4 Others
2.3 Anticancer Drug Market Size by Type
  2.3.1 Anticancer Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Anticancer Drug Market Size Market Share by Type (2020-2025)
2.4 Anticancer Drug Segment by Application
  2.4.1 Immunotherapy
  2.4.2 Targeted Therapy
  2.4.3 Chemotherapy
  2.4.4 Hormonal Therapy
  2.4.5 Others
2.5 Anticancer Drug Market Size by Application
  2.5.1 Anticancer Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Anticancer Drug Market Size Market Share by Application (2020-2025)

3 ANTICANCER DRUG MARKET SIZE BY PLAYER

3.1 Anticancer Drug Market Size Market Share by Player
  3.1.1 Global Anticancer Drug Revenue by Player (2020-2025)
  3.1.2 Global Anticancer Drug Revenue Market Share by Player (2020-2025)
3.2 Global Anticancer Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTICANCER DRUG BY REGION

4.1 Anticancer Drug Market Size by Region (2020-2025)
4.2 Global Anticancer Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anticancer Drug Market Size Growth (2020-2025)
4.4 APAC Anticancer Drug Market Size Growth (2020-2025)
4.5 Europe Anticancer Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Anticancer Drug Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Anticancer Drug Market Size by Country (2020-2025)
5.2 Americas Anticancer Drug Market Size by Type (2020-2025)
5.3 Americas Anticancer Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anticancer Drug Market Size by Region (2020-2025)
6.2 APAC Anticancer Drug Market Size by Type (2020-2025)
6.3 APAC Anticancer Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Anticancer Drug Market Size by Country (2020-2025)
7.2 Europe Anticancer Drug Market Size by Type (2020-2025)
7.3 Europe Anticancer Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anticancer Drug by Region (2020-2025)
8.2 Middle East & Africa Anticancer Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Anticancer Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTICANCER DRUG MARKET FORECAST

10.1 Global Anticancer Drug Forecast by Region (2026-2031)
  10.1.1 Global Anticancer Drug Forecast by Region (2026-2031)
  10.1.2 Americas Anticancer Drug Forecast
  10.1.3 APAC Anticancer Drug Forecast
  10.1.4 Europe Anticancer Drug Forecast
  10.1.5 Middle East & Africa Anticancer Drug Forecast
10.2 Americas Anticancer Drug Forecast by Country (2026-2031)
  10.2.1 United States Market Anticancer Drug Forecast
  10.2.2 Canada Market Anticancer Drug Forecast
  10.2.3 Mexico Market Anticancer Drug Forecast
  10.2.4 Brazil Market Anticancer Drug Forecast
10.3 APAC Anticancer Drug Forecast by Region (2026-2031)
  10.3.1 China Anticancer Drug Market Forecast
  10.3.2 Japan Market Anticancer Drug Forecast
  10.3.3 Korea Market Anticancer Drug Forecast
  10.3.4 Southeast Asia Market Anticancer Drug Forecast
  10.3.5 India Market Anticancer Drug Forecast
  10.3.6 Australia Market Anticancer Drug Forecast
10.4 Europe Anticancer Drug Forecast by Country (2026-2031)
  10.4.1 Germany Market Anticancer Drug Forecast
  10.4.2 France Market Anticancer Drug Forecast
  10.4.3 UK Market Anticancer Drug Forecast
  10.4.4 Italy Market Anticancer Drug Forecast
  10.4.5 Russia Market Anticancer Drug Forecast
10.5 Middle East & Africa Anticancer Drug Forecast by Region (2026-2031)
  10.5.1 Egypt Market Anticancer Drug Forecast
  10.5.2 South Africa Market Anticancer Drug Forecast
  10.5.3 Israel Market Anticancer Drug Forecast
  10.5.4 Turkey Market Anticancer Drug Forecast
10.6 Global Anticancer Drug Forecast by Type (2026-2031)
10.7 Global Anticancer Drug Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Anticancer Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Anticancer Drug Product Offered
  11.1.3 Roche Anticancer Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Celgene
  11.2.1 Celgene Company Information
  11.2.2 Celgene Anticancer Drug Product Offered
  11.2.3 Celgene Anticancer Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Celgene Main Business Overview
  11.2.5 Celgene Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Anticancer Drug Product Offered
  11.3.3 Pfizer Anticancer Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Bristol-Myers Squibb
  11.4.1 Bristol-Myers Squibb Company Information
  11.4.2 Bristol-Myers Squibb Anticancer Drug Product Offered
  11.4.3 Bristol-Myers Squibb Anticancer Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bristol-Myers Squibb Main Business Overview
  11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Novartis
  11.5.1 Novartis Company Information
  11.5.2 Novartis Anticancer Drug Product Offered
  11.5.3 Novartis Anticancer Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Novartis Main Business Overview
  11.5.5 Novartis Latest Developments
11.6 AstraZeneca
  11.6.1 AstraZeneca Company Information
  11.6.2 AstraZeneca Anticancer Drug Product Offered
  11.6.3 AstraZeneca Anticancer Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 AstraZeneca Main Business Overview
  11.6.5 AstraZeneca Latest Developments
11.7 Teva Pharmaceuticals
  11.7.1 Teva Pharmaceuticals Company Information
  11.7.2 Teva Pharmaceuticals Anticancer Drug Product Offered
  11.7.3 Teva Pharmaceuticals Anticancer Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Teva Pharmaceuticals Main Business Overview
  11.7.5 Teva Pharmaceuticals Latest Developments
11.8 Bayer
  11.8.1 Bayer Company Information
  11.8.2 Bayer Anticancer Drug Product Offered
  11.8.3 Bayer Anticancer Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Bayer Main Business Overview
  11.8.5 Bayer Latest Developments
11.9 GlaxoSmithKline
  11.9.1 GlaxoSmithKline Company Information
  11.9.2 GlaxoSmithKline Anticancer Drug Product Offered
  11.9.3 GlaxoSmithKline Anticancer Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 GlaxoSmithKline Main Business Overview
  11.9.5 GlaxoSmithKline Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Anticancer Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Anticancer Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Targeted Drugs
Table 4. Major Players of Cytotoxic Drugs
Table 5. Major Players of Hormonal Drugs
Table 6. Major Players of Others
Table 7. Anticancer Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Anticancer Drug Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Anticancer Drug Market Size Market Share by Type (2020-2025)
Table 10. Anticancer Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Anticancer Drug Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Anticancer Drug Market Size Market Share by Application (2020-2025)
Table 13. Global Anticancer Drug Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Anticancer Drug Revenue Market Share by Player (2020-2025)
Table 15. Anticancer Drug Key Players Head office and Products Offered
Table 16. Anticancer Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Anticancer Drug Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Anticancer Drug Market Size Market Share by Region (2020-2025)
Table 21. Global Anticancer Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Anticancer Drug Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Anticancer Drug Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Anticancer Drug Market Size Market Share by Country (2020-2025)
Table 25. Americas Anticancer Drug Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Anticancer Drug Market Size Market Share by Type (2020-2025)
Table 27. Americas Anticancer Drug Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Anticancer Drug Market Size Market Share by Application (2020-2025)
Table 29. APAC Anticancer Drug Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Anticancer Drug Market Size Market Share by Region (2020-2025)
Table 31. APAC Anticancer Drug Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Anticancer Drug Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Anticancer Drug Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Anticancer Drug Market Size Market Share by Country (2020-2025)
Table 35. Europe Anticancer Drug Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Anticancer Drug Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Anticancer Drug Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Anticancer Drug Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Anticancer Drug Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Anticancer Drug
Table 41. Key Market Challenges & Risks of Anticancer Drug
Table 42. Key Industry Trends of Anticancer Drug
Table 43. Global Anticancer Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Anticancer Drug Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Anticancer Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Anticancer Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Roche Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 48. Roche Anticancer Drug Product Offered
Table 49. Roche Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Roche Main Business
Table 51. Roche Latest Developments
Table 52. Celgene Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 53. Celgene Anticancer Drug Product Offered
Table 54. Celgene Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Celgene Main Business
Table 56. Celgene Latest Developments
Table 57. Pfizer Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 58. Pfizer Anticancer Drug Product Offered
Table 59. Pfizer Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Pfizer Main Business
Table 61. Pfizer Latest Developments
Table 62. Bristol-Myers Squibb Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 63. Bristol-Myers Squibb Anticancer Drug Product Offered
Table 64. Bristol-Myers Squibb Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Bristol-Myers Squibb Main Business
Table 66. Bristol-Myers Squibb Latest Developments
Table 67. Novartis Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 68. Novartis Anticancer Drug Product Offered
Table 69. Novartis Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Novartis Main Business
Table 71. Novartis Latest Developments
Table 72. AstraZeneca Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 73. AstraZeneca Anticancer Drug Product Offered
Table 74. AstraZeneca Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Latest Developments
Table 77. Teva Pharmaceuticals Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 78. Teva Pharmaceuticals Anticancer Drug Product Offered
Table 79. Teva Pharmaceuticals Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Teva Pharmaceuticals Main Business
Table 81. Teva Pharmaceuticals Latest Developments
Table 82. Bayer Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 83. Bayer Anticancer Drug Product Offered
Table 84. Bayer Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Bayer Main Business
Table 86. Bayer Latest Developments
Table 87. GlaxoSmithKline Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 88. GlaxoSmithKline Anticancer Drug Product Offered
Table 89. GlaxoSmithKline Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. GlaxoSmithKline Main Business
Table 91. GlaxoSmithKline Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Anticancer Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anticancer Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Anticancer Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Anticancer Drug Sales Market Share by Country/Region (2024)
Figure 8. Anticancer Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Anticancer Drug Market Size Market Share by Type in 2024
Figure 10. Anticancer Drug in Immunotherapy
Figure 11. Global Anticancer Drug Market: Immunotherapy (2020-2025) & ($ millions)
Figure 12. Anticancer Drug in Targeted Therapy
Figure 13. Global Anticancer Drug Market: Targeted Therapy (2020-2025) & ($ millions)
Figure 14. Anticancer Drug in Chemotherapy
Figure 15. Global Anticancer Drug Market: Chemotherapy (2020-2025) & ($ millions)
Figure 16. Anticancer Drug in Hormonal Therapy
Figure 17. Global Anticancer Drug Market: Hormonal Therapy (2020-2025) & ($ millions)
Figure 18. Anticancer Drug in Others
Figure 19. Global Anticancer Drug Market: Others (2020-2025) & ($ millions)
Figure 20. Global Anticancer Drug Market Size Market Share by Application in 2024
Figure 21. Global Anticancer Drug Revenue Market Share by Player in 2024
Figure 22. Global Anticancer Drug Market Size Market Share by Region (2020-2025)
Figure 23. Americas Anticancer Drug Market Size 2020-2025 ($ millions)
Figure 24. APAC Anticancer Drug Market Size 2020-2025 ($ millions)
Figure 25. Europe Anticancer Drug Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Anticancer Drug Market Size 2020-2025 ($ millions)
Figure 27. Americas Anticancer Drug Value Market Share by Country in 2024
Figure 28. United States Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Anticancer Drug Market Size Market Share by Region in 2024
Figure 33. APAC Anticancer Drug Market Size Market Share by Type (2020-2025)
Figure 34. APAC Anticancer Drug Market Size Market Share by Application (2020-2025)
Figure 35. China Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 39. India Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Anticancer Drug Market Size Market Share by Country in 2024
Figure 42. Europe Anticancer Drug Market Size Market Share by Type (2020-2025)
Figure 43. Europe Anticancer Drug Market Size Market Share by Application (2020-2025)
Figure 44. Germany Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. France Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Anticancer Drug Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Anticancer Drug Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Anticancer Drug Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Anticancer Drug Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 58. APAC Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 59. Europe Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 61. United States Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 62. Canada Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 63. Mexico Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 64. Brazil Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 65. China Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 66. Japan Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 67. Korea Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 69. India Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 70. Australia Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 71. Germany Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 72. France Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 73. UK Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 74. Italy Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 75. Russia Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 76. Egypt Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 77. South Africa Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 78. Israel Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 79. Turkey Anticancer Drug Market Size 2026-2031 ($ millions)
Figure 80. Global Anticancer Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Anticancer Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Anticancer Drug Market Size 2026-2031 ($ millions)